Article
Development and validation of sensitive BCR::ABL1 fusion gene quantitation using next-generation sequencing
2022-12-05
Abstract excerpt
<h4>Background: </h4> BCR::ABL1 fusion has significant prognostic value and is screened for chronic myeloid leukaemia (CML) disease monitoring as a part of routine molecular testing. To overcome the limitations of the current standard real-time quantitative polymerase chain reaction (RQ-PCR), we designed and validated a next-generation sequencing (NGS)-based assay to quantify BCR::ABL1 and ABL1 transcript copy num...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- dce28c3a-fb90-5635-90d3-48a491b1aa4a
- DOI
- 10.21203/rs.3.rs-2328608/v1
